Economic analyses and clinical practice guidelines why not a match made in heaven?

被引:0
作者
Scott D. Ramsey
机构
[1] Fred Hutchinson Cancer Research Center,Department of Medicine
[2] University of Washington,undefined
来源
Journal of General Internal Medicine | 2002年 / 17卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:235 / 237
页数:2
相关论文
共 61 条
[1]  
Wallace JF(2002)The limited incorporation of economic analyses in clinical practice guidelines J Gen Intern Med 17 201-20
[2]  
Weingarten SR(1995)Users’ guides to the medical literature. VIII. How to use clinical practice guidelines. A Are the recommendations valid? The Evidence-Based Medicine Working Group JAMA 274 570-4
[3]  
Chiou C-F(1993)Changing physicians’ practices N Engl J Med 329 1271-3
[4]  
Hayward RS(2001)Design issues for conducting cost-effectiveness analyses alongside clinical trials Annu Rev Public Health 22 129-41
[5]  
Wilson MC(2000)Problems with the interpretation of pharmacoeconomic analyses: a review of submissions to the Australian Pharmaceutical Benefits Scheme JAMA 283 2116-21
[6]  
Tunis SR(2000)A comprehensive league table of cost-utility ratios and a sub-table of “panel-worthy” studies Med Decis Making 20 451-67
[7]  
Bass EB(1994)Internists’ attitudes about clinical practice guidelines Ann Intern Med 120 956-63
[8]  
Guyatt G(1996)Recommendations of the panel on cost-effectiveness in health and medicine JAMA 276 1253-8
[9]  
Greco PJ(2001)Can the health utilities index measure change? Med Care 39 562-74
[10]  
Eisenberg JM(1993)Measuring health-related quality of life Ann Intern Med 118 622-9